Research Paper Volume 16, Issue 6 pp 5545—5566

A pyrimidine metabolism-related signature for prognostic and immunotherapeutic response prediction in hepatocellular carcinoma by integrating analyses


Figure 2. The genetic and transcriptional landscape of PMRGs. (A) The mutation profile of differentially expressed PMRGs in the TCGA-LIHC cohort. (B) The differential expression of PMRGs in HCC between tumor and normal tissues. (C) The CNV patterns of 54 PMRGs within HCC. (D) The locations of the CNV variations of 54 PMRGs on 23 chromosomes.